StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a research note published on Wednesday. The firm issued a buy rating on the stock.
Mannatech Trading Down 2.1 %
Shares of Mannatech stock opened at $8.16 on Wednesday. The company’s fifty day simple moving average is $8.63 and its 200-day simple moving average is $8.78. The company has a market cap of $15.38 million, a price-to-earnings ratio of -6.80 and a beta of 1.20. The company has a current ratio of 1.07, a quick ratio of 0.51 and a debt-to-equity ratio of 0.09. Mannatech has a 1 year low of $7.50 and a 1 year high of $15.10.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its quarterly earnings data on Thursday, March 28th. The company reported ($0.94) earnings per share (EPS) for the quarter. The company had revenue of $32.69 million during the quarter. Mannatech had a negative return on equity of 19.19% and a negative net margin of 1.70%.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Articles
- Five stocks we like better than Mannatech
- Investing In Automotive Stocks
- High-Yield Texas Instruments Could Hit New Highs Soon
- Compound Interest and Why It Matters When Investing
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- How to Invest in Small Cap Stocks
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
